Cargando…

A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatment

Peroxidasin (PXDN), also known as vascular peroxidase-1, is a newly discovered heme-containing peroxidase; it is involved in the formation of extracellular mesenchyme, and it catalyzes various substrate oxidation reactions in humans. However, the role and specific mechanism of PXDN in tumor are uncl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xiaohu, Sun, Qiang, Xu, Chang, Zhou, Zheng, Chen, Xiaoquan, Zhu, Xiuping, Huang, Zhaoshuai, Wang, Weilin, Shi, Yanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380648/ https://www.ncbi.nlm.nih.gov/pubmed/35982948 http://dx.doi.org/10.3389/fonc.2022.952849

Ejemplares similares

PXDN reduces autophagic flux in insulin-resistant cardiomyocytes via modulating FoxO1
por: Li, Chan, et al.
Publicado: (2021)

Biallelic Deletion of Pxdn in Mice Leads to Anophthalmia and Severe Eye Malformation
por: Kim, Hyun-Kyung, et al.
Publicado: (2019)

Alpha-ketoglutarate ameliorates abdominal aortic aneurysm via inhibiting PXDN/HOCL/ERK signaling pathways
por: Liu, Junjun, et al.
Publicado: (2022)

An examination of the regulatory mechanism of Pxdn mutation-induced eye disorders using microarray analysis
por: YANG, YANG, et al.
Publicado: (2016)

Pan-Cancer Prognostic Role and Targeting Potential of the Estrogen-Progesterone Axis
por: Shen, Yu-ting, et al.
Publicado: (2021)

Identification of Novel Variants in LTBP2 and PXDN Using Whole-Exome Sequencing in Developmental and Congenital Glaucoma
por: Micheal, Shazia, et al.
Publicado: (2016)

Machine Learning-Based Comparative Analysis of Pan-Cancer and Pan-Normal Tissues Identifies Pan-Cancer Tissue-Enriched circRNAs Related to Cancer Mutations as Potential Exosomal Biomarkers
por: Wang, Xuezhu, et al.
Publicado: (2021)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021)

The Potential of panHER Inhibition in Cancer
por: Wang, Xiaochun, et al.
Publicado: (2015)

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis
por: Yang, Xiaofeng, et al.
Publicado: (2022)

The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target
por: Gao, Dacheng, et al.
Publicado: (2022)

Differential DNA methylation analysis of SUMF2, ADAMTS5, and PXDN provides novel insights into colorectal cancer prognosis prediction in Taiwan
por: Su, Jing-Quan, et al.
Publicado: (2022)

Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer
por: Zhou, Cankun, et al.
Publicado: (2022)

Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response
por: Das, Shaoli, et al.
Publicado: (2019)

Pan-cancer analysis of the prognostic and immunological role of GJB2: a potential target for survival and immunotherapy
por: Jia, Yuting, et al.
Publicado: (2023)

A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer
por: Zhu, Weizhen, et al.
Publicado: (2022)

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022)

Pan-cancer analysis identified OAS1 as a potential prognostic biomarker for multiple tumor types
por: Jiang, Shan, et al.
Publicado: (2023)

Prognostic Pathways Guide Drug Indications in Pan-Cancers
por: Meng, Fanlin, et al.
Publicado: (2022)

Pan-cancer analysis of kinesin family members with potential implications in prognosis and immunological role in human cancer
por: Zhong, Ming, et al.
Publicado: (2023)

Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression
por: Chen, Xi, et al.
Publicado: (2022)

Integrative Pan-Cancer Analysis of KIF15 Reveals Its Diagnosis and Prognosis Value in Nasopharyngeal Carcinoma
por: Mi, Jinglin, et al.
Publicado: (2022)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Pan-Cancer Analysis Reveals Genomic and Clinical Characteristics of TRPV Channel-Related Genes
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma
por: Wang, Zhen, et al.
Publicado: (2022)

A Systematic Pan-Cancer Analysis of CASP3 as a Potential Target for Immunotherapy
por: Zhou, Zheng, et al.
Publicado: (2022)

Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden
por: Yuan, Hong, et al.
Publicado: (2021)

The Favorable Prognostic Factors for Superior Sulcus Tumor: A Systematic Review and Meta-Analysis
por: Hao, Xiaohu, et al.
Publicado: (2020)

Pan-cancer investigation of C-to-U editing reveals its important role in cancer development and new targets for cancer treatment
por: Guo, Mengbiao, et al.
Publicado: (2023)

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy
por: Shen, Shuai, et al.
Publicado: (2020)

Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors
por: Li, Minde, et al.
Publicado: (2021)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

The Role of Microtubules in Pancreatic Cancer: Therapeutic Progress
por: Albahde, Mugahed Abdullah Hasan, et al.
Publicado: (2021)

HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer
por: Liu, Chengdong, et al.
Publicado: (2021)

The role of toll-like receptors (TLRs) in pan-cancer
por: Huang, Runzhi, et al.
Publicado: (2022)

An Integrated Pan-Cancer Analysis of ADAMTS12 and Its Potential Implications in Pancreatic Adenocarcinoma
por: Song, Caiyun, et al.
Publicado: (2022)

A Pan-Cancer Bioinformatic Analysis of RAD51 Regarding the Values for Diagnosis, Prognosis, and Therapeutic Prediction
por: Liu, Hengrui, et al.
Publicado: (2022)

Pan-cancer analysis of trophinin-associated protein with potential implications in clinical significance, prognosis, and tumor microenvironment in human cancers
por: Li, Zhenfen, et al.
Publicado: (2022)

Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer
por: Lv, Wenming, et al.
Publicado: (2022)

Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy
por: Wang, Zhengfeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u65a7j20ou5tnk5qqtb98mtl4o